Each quarter, The Leading Edge newsletter highlights new topics to give our referring physicians the latest news on leading-edge therapies that SCCA physicians are offering.2015 | 2014 | 2013 | 2012 | 2011 | 2010 | | 2008
In this issue, we introduce a new Phase I clinical trials unit for patients participating in Phase I clinical research and several clinical trials now seeking patients including those with malignant glioma, prostate cancer, and acute myeloid leukemia. We also discuss the efficacy of VATS lobectomy for lung cancer treatment.
Each quarter of The Leading Edge newsletter, we'll highlight the latest news on leading-edge research and therapies that SCCA physicians are offering. In this issue we're featuring FES PET – It’s the new wave of advanced imaging technology; New T-cell lymphoma project at SCCA; Evaluation of first-line treatments of extensive stage small-cell lung cancer; and Outcomes research a new focus at SCCA Prostate Cancer Center.
2015 | 2014 | 2013 | 2012 | 2011 | 2010 | | 2008